The neurology of mitochondrial DNA disease

Lancet Neurology

Volumn 1, Issue 6, 2002, Pages 343-351

  McFarland, Robert ^a   Taylor, Robert W ^a   Turnbull, Douglass M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ASCORBIC ACID; CREATINE; MENADIONE; MITOCHONDRIAL DNA; UBIQUINONE; VALPROIC ACID;

ATAXIA; BRAIN DISEASE; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DETERMINATION; DNA STRUCTURE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DISORDER; GENOME ANALYSIS; GENOMICS; HEREDITARY OPTIC ATROPHY; HISTOPATHOLOGY; HUMAN; KEARNS SAYRE SYNDROME; LEIGH DISEASE; LIVER TOXICITY; MEDICAL ASSESSMENT; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME; MOLECULAR GENETICS; NEUROPATHOLOGY; NEUROPATHY; OPHTHALMOPLEGIA; PATIENT CARE; PEARSON SYNDROME; PHENOTYPE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; SYNDROME; TREATMENT CONTRAINDICATION; CHEMISTRY; GENETICS; NEUROLOGIC DISEASE; PHYSIOLOGY;

DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIAL DISEASES; NERVOUS SYSTEM DISEASES;

EID: 0141453835     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(02)00159-X     Document Type: Review

References (66)

1. Marguils L. Origin of eukaryotic cells. 1970;Yale University Press, New Haven.
2. Anderson S., Bankier A.T., Barrell B.G., et al. Sequence and organization of the human mitochondrial genome. Nature. 290:1981;457-465.
3. Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M., Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 23:1999;147.
4. Chinnery P.F., Johnson M.A., Wardell T.M., et al. Epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol. 48:2000;188-193.
5. Cottrell D.A., Blakely E.L., Johnson M.A., Borthwick G.M., Ince P.I., Turnbull D.M. Mitochondrial DNA mutations in disease and ageing. Ageing vulnerability: causes and interventions-number 235 (Novartis Foundation Symposium). 2001;234-246 Wiley, Chichester.
6. Sutovsky P., Moreno R.D., Ramalho-Santos J., Dominko T., Simerly C., Schatten G. Ubiquitin tag for sperm mitochondria. Nature. 402:1999;371-372.
7. Chinnery P.F., Thorburn D.R., Samuels D.C., et al. The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? Trends Genet. 16:2000;500-505.
8. Jenuth J.P., Peterson A.C., Shoubridge E.A. Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nat Genet. 16:1997;93-95.
9. Boulet L., Karpati G., Shoubridge E.A. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet. 51:1992;1187-1200.
10. Chomyn A., Martinuzzi A., Yoneda M., et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA. 89:1992;4221-4225.
11. Sciacco M., Bonilla E., Schon E.A., DiMauro S., Moraes C.T. Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet. 3:1994;13-19.
12. Hammans S.R., Sweeney M.G., Brockington M., et al. The mitochondrial DNA transfer RNA(Lys)A - >(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF): relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain. 116:1993;617-632.
13. Chinnery P.F., Howell N., Lightowlers R.N., Turnbull D.M. MELAS and MERRF: the relationship between maternal mutation load and the frequency of clinically affected offspring. Brain. 121:1998;1889-1894.
14. MITOMAP: a human mitochondrial genome database: http://www.mitomap.org/, accessed September 2002.
15. DiMauro S., Schon E.A. Mitochondrial DNA mutations in human disease. Am J Med Genet. 106:2001;18-26.
16. Moraes C.T., DiMauro S., Zeviani M., et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med. 320:1989;1293-1299.
17. Laforet P., Lombes A., Eymard B., et al. Chronic progressive external ophthalmoplegia with ragged-red fibers: clinical, morphological and genetic investigations in 43 patients. Neuromuscul Disord. 5:1995;399-413.
18. Zeviani M., Servidei S., Gellera C., Bertini E., DiMauro S., DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature. 339:1989;309-311.
19. Spelbrink J.N., Li F.Y., Tiranti V., et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet. 28:2001;223-231.
20. Kaukonen J., Juselius J.K., Tiranti V., et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science. 289:2000;782-785.
21. Kaukonen J., Zeviani M., Comi G.P., Piscaglia M.-G., Peltonen L., Suomalainen A. A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophthalmoplegia. Am J Hum Genet. 65:1999;256-261.
22. Van Goethem G., Dermaut B., Lofgren A., Martin J.-J., Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet. 28:2001;211-212.
23. Bohlega S., Tanji K., Santorelli F.M., Hirano M., al-Jishi A., DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology. 46:1996;1329-1334.
24. Bardosi A., Creutzfeldt W., DiMauro S., et al. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase: a new mitochondrial multisystem disorder. Acta Neuropathol. 74:1987;248-258.
25. Nishino I., Spinazzola A., Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 283:1999;689-692.
26. Spinazzola A., Marti R., Nishino I., et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem. 277:2002;4128-4133.
27. Mandel H., Szargel R., Labay V., et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 29:2001;337-341.
28. Saada A., Shaag A., Mandel H., Nevo Y., Eriksson S., Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 29:2001;342-344.
29. Hasegawa H., Matsuoka T., Goto Y., Nonaka I. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ann Neurol. 6:1991;601-605.
30. Goto Y., Nonaka I., Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 348:1990;651-653.
31. van den Ouweland J.M., Lemkes H.H.P., Ruitenbeek W., et al. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet. 1:1992;368-371.
32. Ciafaloni E., Ricci E., Shanske S., et al. MELAS: clinical features, biochemistry and molecular genetics. Ann Neurol. 4:1992;391-398.
33. Shoffner J.M., Lott M.T., Lezza A.M., Seibel P., Ballinger S.W., Wallace D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell. 61:1990;931-937.
34. Silvestri G., Moraes C.T., Shanske S., Oh S.J., DiMauro S. A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet. 51:1992;213-217.
35. Larsson N.G., Tulinius M.H., Holme E., Oldfors A. Pathogenetic aspects of the A8344G mutation of mitochondrial DNA associated with MERRF syndrome and multiple symmetric lipomas. Muscle Nerve. 3:1995;S102-S106.
36. Silvestri G., Ciafaloni E., Santorelli F.M., et al. Clinical features associated with the A - transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology. 43:1993;200-206.
37. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry. 14:1951;216-221.
38. Tatuch Y., Christodoulou J., Feigenbaum A., et al. Heteroplasmic mtDNA mutation (T-to-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet. 50:1992;852-858.
39. Shoffner J.M., Fernhoff P.M., Krawiecki N.S., et al. Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology. 42:1992;2168-2174.
40. Thyagarajan D., Shanske S., Vazquez-Memije M., De Vivo D., DiMauro S. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol. 38:1995;468-472.
41. Carrozzo R., Tessa A., Vazquez-Memije M.E., et al. The T9176G mtDNA mutation severely affects ATP production and results in Leigh syndrome. Neurology. 56:2001;687-690.
42. Pastores G.M., Santorelli F.M., Shanske S., et al. Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial DNA point mutation (T8993G). Am J Med Genet. 50:1994;265-271.
43. de Vries D.D., van Engelen B.G., Gabreels F.J., Ruitenbeek W., van Oost B.A. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol. 34:1993;410-412.
44. Holt I.J., Harding A.E., Petty R.K.H., Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 46:1990;428-433.
45. Wallace D.C., Singh G., Lott M.T. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 242:1988;1427-1430.
46. Newman N.J., Lott M.T., Wallace D.C. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthal. 111:1991;750-762.
47. Johns D.R., Heher K.L., Miller N.R., Smith K.H. Leber's hereditary optic neuropathy: clinical manifestations of the 14484 mutation. Arch Ophthalmol. 111:1993;495-498.
48. Wallace D.C. A new manifestation of Leber's disease and a new explanation for the agency responsible for its unusual pattern of inheritance. Brain. 93:1970;121-132.
49. Howell N., Bindoff L.A., McCullough D.A., et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet. 49:1991;939-950.
50. Jackson M.J., Schaefer J.A., Johnson M.A., Morris A.A., Turnbull D.M., Bindoff L.A. Presentation and clinical investigation of mitochondrial respiratory chain disease: a study of 51 patients. Brain. 118:1995;339-357.
51. Brierly E.J., Johnson M.A., Bowman A., et al. Mitochondrial function in muscle from elderly athletes. Ann Neurol. 41:1997;114-116.
52. McFarland R., Clark K.M., Morris A.A., et al. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet. 30:2002;145-146.
53. Taylor R.W., Chinnery P.F., Haldane F., et al. MELAS associated with a mutation in the valine transfer RNA gene of mitochondrial DNA. Ann Neurol. 40:1996;459-462.
54. Taylor R.W., Singh-Kler R., Hayes C.M., Smith P.E., Turnbull D.M. Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene. Ann Neurol. 50:2001;104-107.
55. Musumeci O., Naini A., Slonim A.E., et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology. 56:2001;849-855.
56. Prezant T.R., Agapian J.V., Bohlman M.C., et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic induced and non-syndromic deafness. Nat Genet. 4:1993;289-294.
57. Sue C.M., Tanji K., Hadjigeorgiou G., et al. Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology. 52:1999;1905-1908.
58. Seibel P., Trappe J., Villani G., Klopstock T., Papa S., Reichmann H. Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res. 23:1995;10-17.
59. Kolesnikova O.A., Entelis N.S., Mireau H., Fox T.D., Martin R.P., Tarassov I.A. Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm. Science. 28:2000;1931-1933.
60. Manfredi G., Fu J., Ojaimi J., Sadlock J.E., Kwong J.Q., Schon E.A. Rescue of an ATP synthesis deficiency in mtDNA-mutant human cells by transfer of MTATP6, a mtDNA-encoded gene, to the nucleus. Nat Genet. 30:2002;394-399.
61. Srivastava S., Moraes C.T. Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease. Hum Mol Genet. 10:2001;3093-3099.
62. Taylor R.W., Chinnery P.F., Turnbull D.M., Lightowlers R.N. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet. 15:1997;212-215.
63. Muratovska A., Lightowlers R.N., Taylor R.W., et al. Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res. 29:2001;1852-1863.
64. Chinnery P.F., Taylor R.W., Diekert K., Lill R., Turnbull D.M., Lightowlers R.N. Peptide nucleic acid and delivery to human mitochondria. Gene Ther. 7:2000;813.
65. Clark K.M., Bindoff L.A., Lightowlers R.N., et al. Reversal of a mitochondrial DNA defect in human skeletal muscle. Nature Genet. 16:1997;222-224.
66. Shoubridge E.A., Johns T., Karpati G. Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum Mol Genet. 6:1997;2239-2242.